巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    Calithera Biosciences

    CALA
    2.650
    0.050
    1.92%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・Calithera Biosciences - 延遲價格・最後更新於 06/07 7:32
    最高位
    2.680
    最低位
    2.620
    開市價
    --
    前收市價
    2.600
    成交量(千)
    0.20
    成交額(百萬)
    0.01
    買入
    2.610
    賣出
    2.670
    每手股數
    --
    市值(百萬)
    12.88
    市盈率
    --
    息率
    --
    差價
    --
    52週高低
    49.800 - 2.300
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    Calithera Biosciences
    證券代碼
    CALA.US
    所屬板塊
    Biotechnology
    公司業務
    Calithera Biosciences Inc is a clinical-stage pharmaceutical company. The business activity of the firm functions through the region of the US. It focuses on discovering and developing small molecule drugs directed against tumor and immune cell targets that control key metabolic pathways in the tumor microenvironment. Its lead product candidate is CB-839, an inhibitor of glutaminase for the treatment of solid tumors. Its other product candidate, CB-1158, is being developed for hematology and oncology indications.
    發行量
    97236174
    公司總部
    343 Oyster Point Boulevard, Suite 200
    公司網址
    https://www.calithera.com
    公司電郵
    ir@calithera.com
    公司電話
    +1 650 870-1000
    暫無內容

    關於

    Calithera Biosciences(CALA.US)所屬的行業板塊為Biotechnology。
    Calithera Biosciences Inc is a clinical-stage pharmaceutical company. The business activity of the firm functions through the region of the US. It focuses on discovering and developing small molecule drugs directed against tumor and immune cell targets that control key metabolic pathways in the tumor microenvironment. Its lead product candidate is CB-839, an inhibitor of glutaminase for the treatment of solid tumors. Its other product candidate, CB-1158, is being developed for hematology and oncology indications.
    詳細公司背景可參考: https://www.calithera.com